{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:39Z","timestamp":1787440959275,"version":"build-2736575974"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt Foundation","doi-asserted-by":"publisher","award":["88881.699297\/2022\\u201301"],"award-info":[{"award-number":["88881.699297\/2022\\u201301"]}],"id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023684","name":"Fraunhofer Cluster of Excellence for Immune-Mediated Diseases","doi-asserted-by":"publisher","award":["CIMD_CED-AhR"],"award-info":[{"award-number":["CIMD_CED-AhR"]}],"id":[{"id":"10.13039\/501100023684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003185","name":"Fraunhofer Society for the Advancement of Applied Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01KC2301A"],"award-info":[{"award-number":["01KC2301A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119621","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:27:33Z","timestamp":1781065653000},"page":"119621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PPAR\u03b3 controls I3C-mediated anti-inflammatory effects through the NF-\u03baB\/IL-6 pathway on gut inflammation models"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9158-1194","authenticated-orcid":false,"given":"Gustavo Henrique Oliveira","family":"da Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9861-7928","authenticated-orcid":false,"given":"Melina Katja","family":"Biermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Kotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Riemschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Schiefke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8560-648X","authenticated-orcid":false,"given":"J\u00f6rg","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2026.119621_bib1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41575-025-01097-1","article-title":"The global burden of inflammatory bowel disease: from 2025 to 2045","volume":"22","author":"Kaplan","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib2","doi-asserted-by":"crossref","first-page":"23517","DOI":"10.1038\/s41598-025-08744-2","article-title":"Etiological mechanisms underlying the hazard factors and inflammatory bowel disease: a prospective cohort study","volume":"15","author":"Tao","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2026.119621_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ibd\/izae075","article-title":"NOD2 and Crohn's disease clinical practice: from epidemiology to diagnosis and therapy, rewired","volume":"31","author":"Kayali","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119621_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119621_bib5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3748\/wjg.v29.i7.1157","article-title":"Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets","volume":"29","author":"Otte","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2026.119621_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119621_bib7","first-page":"1","article-title":"Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components","volume":"669","author":"Martin","year":"2009","journal-title":"Mutat. Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119621_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0165-6147(00)01559-5","article-title":"PPAR-g agonists: therapeutic role in diabetes, inflammation and cancer","volume":"21","author":"Murphy","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2026.119621_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103214","article-title":"PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis","volume":"146","author":"Geng","year":"2024","journal-title":"J. Autoimmun."},{"issue":"23","key":"10.1016\/j.biopha.2026.119621_bib10","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.3390\/ijms21239329","article-title":"Altered PPARgamma expression promotes myelin-induced foam cell formation in macrophages in multiple sclerosis","volume":"21","author":"Wouters","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119621_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/ibd\/izaa273","article-title":"PPAR\u03b3: the central mucus barrier coordinator in ulcerative colitis","volume":"27","author":"Fang","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"10.1016\/j.biopha.2026.119621_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167300","article-title":"Identification and experimental validation of immune-related gene PPARG is involved in ulcerative colitis","volume":"1870","author":"Li","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"8","key":"10.1016\/j.biopha.2026.119621_bib13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/cimb47080616","article-title":"Molecular subtypes and biomarkers of ulcerative colitis revealed by sphingolipid metabolism-related genes: insights from machine learning and molecular dynamics","volume":"47","author":"Li","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib14","doi-asserted-by":"crossref","first-page":"18094","DOI":"10.1038\/s41598-024-69322-6","article-title":"Identifying polyamine related biomarkers in diagnosis and treatment of ulcerative colitis by integrating bulk and single-cell sequencing data","volume":"14","author":"Wei","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib15","doi-asserted-by":"crossref","first-page":"11519","DOI":"10.1038\/s41598-021-91124-3","article-title":"Systems biology approach highlights mechanistic differences between Crohn's disease and ulcerative colitis","volume":"11","author":"Ruiz Castro","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2026.119621_bib16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/ecco-jcc\/jjac021","article-title":"Identification of gene expression profiles associated with an increased risk of post-operative recurrence in Crohn's disease","volume":"16","author":"Ngollo","year":"2022","journal-title":"J. Crohns Colitis"},{"issue":"2","key":"10.1016\/j.biopha.2026.119621_bib17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10753-019-01138-3","article-title":"Pioglitazone attenuates experimental colitis-associated hyperalgesia through improving the intestinal barrier dysfunction","volume":"43","author":"Huang","year":"2020","journal-title":"Inflammation"},{"issue":"7","key":"10.1016\/j.biopha.2026.119621_bib18","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1053\/j.gastro.2007.04.017","article-title":"A randomized, placebo-controlled trial of the PPAR\u03b3 ligand rosiglitazone for active ulcerative colitis","volume":"132","author":"Lewis","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biopha.2026.119621_bib19","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1053\/j.gastro.2007.12.012","article-title":"Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial","volume":"134","author":"Lewis","year":"2008","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.biopha.2026.119621_bib20","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/ph15121538","article-title":"Pioglitazone has a null association with inflammatory bowel disease in patients with type 2 diabetes mellitus","volume":"15","author":"Tseng","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.biopha.2026.119621_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/ph16050679","article-title":"Rosiglitazone does not affect the risk of inflammatory bowel disease: a retrospective cohort study in Taiwanese type 2 diabetes patients","volume":"16","author":"Tseng","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.biopha.2026.119621_bib22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/ibd\/izx079","article-title":"A novel topical PPARgamma agonist induces PPARgamma activity in ulcerative colitis mucosa and prevents and reverses inflammation in induced colitis models","volume":"24","author":"Da Silva","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119621_bib23","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/med.21893","article-title":"Inflammatory bowel disease biomarkers","volume":"42","author":"Liu","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119621_bib24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1124\/jpet.107.129122","article-title":"Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist","volume":"324","author":"Linard","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119621_bib25","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1142\/S0192415X25500727","article-title":"Eugenol exerted significant anti-oxidant and anti-inflammatory effects on experimental colitis via directly acting on PPAR-g","volume":"53","author":"Huang","year":"2025","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.biopha.2026.119621_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5498115","article-title":"alpha-Bisabolol mitigates colon inflammation by stimulating colon PPAR-gamma transcription factor: in vivo and in vitro study","volume":"2022","author":"Venkataraman","year":"2022","journal-title":"PPAR Res."},{"key":"10.1016\/j.biopha.2026.119621_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bcp.2018.07.032","article-title":"From TCDD-mediated toxicity to searches of physiologic AHR functions","volume":"155","author":"Bock","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119621_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115626","article-title":"Ligands and agonists of the aryl hydrocarbon receptor AhR: Facts and Myths","volume":"213","author":"Sladekova","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119621_bib29","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1053\/j.gastro.2017.11.024","article-title":"Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis","volume":"154","author":"Naganuma","year":"2018","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.biopha.2026.119621_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241337","article-title":"Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial","volume":"15","author":"Uchiyama","year":"2020","journal-title":"PLoS. One"},{"issue":"5","key":"10.1016\/j.biopha.2026.119621_bib31","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/ijerph18052262","article-title":"Indol-3-carbinol and quercetin ameliorate chronic DSS-induced colitis in C57BL\/6 mice by AhR-mediated anti-inflammatory mechanisms","volume":"18","author":"Riemschneider","year":"2021","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"23","key":"10.1016\/j.biopha.2026.119621_bib32","doi-asserted-by":"crossref","first-page":"13072","DOI":"10.3390\/ijms252313072","article-title":"AhR-induced anti-inflammatory effects on a Caco-2\/THP-1 co-culture model of intestinal inflammation are mediated by PPARgamma","volume":"25","author":"da Rocha","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119621_bib33","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1172\/JCI24792","article-title":"Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF- B decoy oligonucleotides","volume":"115","author":"Fichtner-Feigl","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"16","key":"10.1016\/j.biopha.2026.119621_bib34","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.3390\/ijms23169344","article-title":"Inflammatory bowel disease: a review of pre-clinical murine models of human disease","volume":"23","author":"Katsandegwaza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcmgh.2017.02.010","article-title":"Uncovering pathogenic mechanisms of inflammatory bowel disease using mouse models of Crohn\u2019s disease\u2013like ileitis: what is the right model?","volume":"4","author":"Cominelli","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib36","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41598-019-38524-8","article-title":"Long-term in vitro 3D hydrogel co-culture model of inflammatory bowel disease","volume":"9","author":"Dosh","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119621_bib37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.tibtech.2024.10.002","article-title":"Revolutionizing IBD research with on-chip models of disease modeling and drug screening","volume":"43","author":"Yilmaz","year":"2025","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119621_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s44164-022-00017-w","article-title":"vitro models and ex vivo systems used in inflammatory bowel disease","volume":"1","author":"Joshi","year":"2022","journal-title":"Vitr. Models"},{"issue":"10","key":"10.1016\/j.biopha.2026.119621_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276195","article-title":"Generation of human colon organoids from healthy and inflammatory bowel disease mucosa","volume":"17","author":"Dotti","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41420-023-01556-1","article-title":"Stem cell-derived intestinal organoids: a novel modality for IBD","volume":"9","author":"Tian","year":"2023","journal-title":"Cell. Death Discov."},{"issue":"8","key":"10.1016\/j.biopha.2026.119621_bib41","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.3390\/ijms24087427","article-title":"Development of an Inflammation-Triggered In Vitro \u201cLeaky Gut\u201d Model Using Caco-2\/HT29-MTX-E12 Combined with Macrophage-like THP-1 Cells or Primary Human-Derived Macrophages","volume":"24","author":"Le","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119621_bib42","article-title":"High-Throughput Human Gut Immune Co-Culture Model for Evaluating Inflammatory Bowel Disease Anti-Inflammatory Therapies","volume":"5","author":"Peddibhotla","year":"2025","journal-title":"BioRxiv"},{"issue":"3","key":"10.1016\/j.biopha.2026.119621_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0023677217742681","article-title":"A refined and translationally relevant model of chronic DSS colitis in BALB\/c mice","volume":"52","author":"Hoffmann","year":"2018","journal-title":"Lab. Anim."},{"key":"10.1016\/j.biopha.2026.119621_bib44","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of Image Analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"21","key":"10.1016\/j.biopha.2026.119621_bib45","doi-asserted-by":"crossref","first-page":"12781","DOI":"10.3390\/ijms232112781","article-title":"Pioglitazone Attenuates the Effects of Peripheral Inflammation in a Human In Vitro Blood-Brain Barrier Model","volume":"23","author":"Rocha","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127551","article-title":"Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22-dependent manner","volume":"5","author":"Busbee","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.biopha.2026.119621_bib47","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0016-5085(03)00271-3","article-title":"Impaired expression of peroxisome proliferator-activated receptor \u03b3 in ulcerative colitis","volume":"124","author":"Dubuquoy","year":"2003","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119621_bib48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13596-020-00452-8","article-title":"Indole-3-carbinol alleviates carbon tetrachloride-induced liver injury by inhibiting inflammatory response and regulating lipid metabolism","volume":"21","author":"Ahn","year":"2020","journal-title":"Adv. Tradit. Med."},{"issue":"12","key":"10.1016\/j.biopha.2026.119621_bib49","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jnutbio.2011.12.005","article-title":"Indole-3-carbinol prevents diet-induced obesity through modulation of multiple genes related to adipogenesis, thermogenesis or inflammation in the visceral adipose tissue of mice","volume":"23","author":"Choi","year":"2012","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119621_bib50","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ijo.2012.158","article-title":"Indole-3-carbinol directly targets SIRT1 to inhibit adipocyte differentiation","volume":"37","author":"Choi","year":"2013","journal-title":"Int. J. Obes. (Lond. )"},{"issue":"2","key":"10.1016\/j.biopha.2026.119621_bib51","doi-asserted-by":"crossref","first-page":"G657","DOI":"10.1152\/ajpgi.00381.2006","article-title":"Expression of peroxisome proliferator-activated receptor-\u03b3 in macrophage suppresses experimentally induced colitis","volume":"292","author":"Shah","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"47","key":"10.1016\/j.biopha.2026.119621_bib52","doi-asserted-by":"crossref","first-page":"82541","DOI":"10.18632\/oncotarget.19657","article-title":"C1q\/Tumor necrosis factor-related protein-3 protects macrophages against LPS-induced lipid accumulation, inflammation and phenotype transition via PPAR\u03b3 and TLR4-mediated pathways","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib53","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3892\/etm.2021.10146","article-title":"Morphine enhances LPS-induced macrophage apoptosis through a PPARgamma-dependent mechanism","volume":"22","author":"Lin","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2026.119621_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.829870","article-title":"PPARgamma Ameliorates Mycobacterium tuberculosis H37Ra-Induced Foamy Macrophage Formation via the ABCG1-Dependent Cholesterol Efflux Pathway in THP-1 Macrophages","volume":"13","author":"Ye","year":"2022","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119621_bib55","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.193.7.827","article-title":"Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (RXR)\/Peroxisome Proliferator\u2013activated Receptorg (PPARg) Heterodimer: A Basis for New Therapeutic Strategies","volume":"193","author":"Desreumaux","year":"2001","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119621_bib56","doi-asserted-by":"crossref","first-page":"E788","DOI":"10.1152\/ajpendo.00337.2011","article-title":"25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARgamma signaling in human THP-1 macrophages","volume":"302","author":"Xu","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.biopha.2026.119621_bib57","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00029330-200705010-00011","article-title":"Effects of curcumin on peroxisome proliferator-activated receptor \u03b3 expression and nuclear translocation\/redistribution in culture-activated rat hepatic stellate cells","volume":"120","author":"Cheng","year":"2007","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.biopha.2026.119621_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2009.10.038","article-title":"12\/15-Lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia\/reperfusion","volume":"1307","author":"Xu","year":"2010","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib59","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1038\/s41598-018-36052-5","article-title":"Elevated pre-activation basal level of nuclear NF-kappaB in native macrophages accelerates LPS-induced translocation of cytosolic NF-kappaB into the cell nucleus","volume":"9","author":"Bagaev","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119621_bib60","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ncomms2270","article-title":"PPARgamma is an E3 ligase that induces the degradation of NFkappaB\/p65","volume":"3","author":"Hou","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119621_bib61","doi-asserted-by":"crossref","first-page":"930.2","DOI":"10.1096\/fasebj.28.1_supplement.930.2","article-title":"Mutation in the PPARG ligand binding domain impairs PPARG-mediated turnover of the p65 subunit of NF-\u03baB","volume":"28","author":"Mukoda","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2026.119621_bib62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcp.2018.06.016","article-title":"Activation of aryl hydrocarbon receptor regulates the LPS\/IFNgamma-induced inflammatory response by inducing ubiquitin-proteosomal and lysosomal degradation of RelA\/p65","volume":"155","author":"Dominguez-Acosta","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119621_bib63","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X","article-title":"Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells","volume":"31","author":"Gosset","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2026.119621_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118475","article-title":"Immunomodulatory effects of phthiocol: an aryl hydrocarbon receptor ligand regulating conventional dendritic cells and macrophages to alleviate sepsis and lupus severity","volume":"191","author":"Kunanopparat","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119621_bib65","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.2147\/JIR.S329091","article-title":"The flavonoid kurarinone regulates macrophage functions via aryl hydrocarbon receptor and alleviates intestinal inflammation in irritable bowel syndrome","volume":"14","author":"Xu","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119621_bib66","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbrc.2015.10.051","article-title":"Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis","volume":"467","author":"Chen","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2026.119621_bib67","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.bbrc.2018.07.098","article-title":"The LncRNA MALAT1 regulates CD80 transcription via the NF-kappaB signaling pathway in the A549\u00a0cell line","volume":"503","author":"Juan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.biopha.2026.119621_bib68","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1042\/CS20220531","article-title":"M1\/M2 macrophages and their overlaps - myth or reality?","volume":"137","author":"Strizova","year":"2023","journal-title":"Clin. Sci."},{"key":"10.1016\/j.biopha.2026.119621_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104475","article-title":"CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization","volume":"372","author":"Sun","year":"2022","journal-title":"Cell. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119621_bib70","first-page":"S868","article-title":"The natural compound dansameum reduces foam cell formation by downregulating CD36 and peroxisome proliferator-activated receptor-gamma","volume":"13","author":"Park","year":"2018","journal-title":"Express. Pharmacogn. Mag."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12944-024-02049-5","article-title":"Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG\/CD36 pathway","volume":"23","author":"Wang","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119621_bib72","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1021\/jf9032443","article-title":"Dietary compound quercitrin dampens VEGF induction and PPARgamma activation in oxidized LDL-exposed murine macrophages: association with scavenger receptor CD36","volume":"58","author":"Choi","year":"2010","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/08830185.2017.1380200","article-title":"Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals","volume":"37","author":"Vidya","year":"2018","journal-title":"Int. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119621_bib74","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.0801217","article-title":"Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6\/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model","volume":"184","author":"Matsumoto","year":"2010","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.biopha.2026.119621_bib75","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1080\/15384101.2021.1995128","article-title":"MiR-125-5p\/IL-6R axis regulates macrophage inflammatory response and intestinal epithelial cell apoptosis in ulcerative colitis through JAK1\/STAT3 and NF-kappaB pathway","volume":"20","author":"Yao","year":"2021","journal-title":"Cell. Cycle"},{"issue":"3","key":"10.1016\/j.biopha.2026.119621_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085345","article-title":"Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene","volume":"9","author":"Al-Sadi","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2026.119621_bib77","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1172\/JCI138697","article-title":"Inactivation of paracellular cation-selective claudin-2 channels attenuates immune-mediated experimental colitis in mice","volume":"130","author":"Raju","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"36","key":"10.1016\/j.biopha.2026.119621_bib78","doi-asserted-by":"crossref","first-page":"31263","DOI":"10.1074\/jbc.M111.238147","article-title":"Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium","volume":"286","author":"Suzuki","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/gut.2006.094375","article-title":"Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease","volume":"56","author":"Zeissig","year":"2007","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.biopha.2026.119621_bib80","doi-asserted-by":"crossref","first-page":"C527","DOI":"10.1152\/ajpcell.00199.2018","article-title":"Molecular mechanisms of somatostatin-mediated intestinal epithelial barrier function restoration by upregulating claudin-4 in mice with DSS-induced colitis","volume":"315","author":"Cai","year":"2018","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119621_bib81","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00280-013-2238-2","article-title":"Disruption of ZO-1\/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis","volume":"72","author":"Hamada","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib82","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1038\/s41598-018-24706-3","article-title":"The role of macrophage migration inhibitory factor in the function of intestinal barrier","volume":"8","author":"Vujicic","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119621_bib83","doi-asserted-by":"crossref","first-page":"116","DOI":"10.12659\/MSM.881712","article-title":"Activated and inactivated PPARs-g modulate experimentally induced colitis in rats","volume":"17","author":"Celinski","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2026.119621_bib84","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fcell.2020.00363","article-title":"Characterization of human colon organoids from inflammatory bowel disease patients","volume":"8","author":"d'Aldebert","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119621_bib85","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41421-018-0036-z","article-title":"Monolayer culture of intestinal epithelium sustains Lgr5(+) intestinal stem cells","volume":"4","author":"Liu","year":"2018","journal-title":"Cell. Discov."},{"issue":"1","key":"10.1016\/j.biopha.2026.119621_bib86","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1038\/s41467-022-31587-8","article-title":"Tight junction channel regulation by interclaudin interference","volume":"13","author":"Shashikanth","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119621_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1223032","article-title":"Human organoids are superior to cell culture models for intestinal barrier research","volume":"11","author":"Kollmann","year":"2023","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119621_bib88","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fcimb.2020.00272","article-title":"A human 2D primary organoid-derived epithelial monolayer model to study host-pathogen interaction in the small intestine","volume":"10","author":"Roodsant","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:01:19Z","timestamp":1787439679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":88,"alternative-id":["S0753332226006578"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119621","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b3 controls I3C-mediated anti-inflammatory effects through the NF-\u03baB\/IL-6 pathway on gut inflammation models","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119621"}}